MARKET

CELU

CELU

Celularity Inc
NASDAQ
1.200
-0.010
-0.83%
After Hours: 1.219 +0.019 +1.56% 16:20 03/26 EDT
OPEN
1.230
PREV CLOSE
1.210
HIGH
1.230
LOW
1.155
VOLUME
45.15K
TURNOVER
--
52 WEEK HIGH
4.350
52 WEEK LOW
1.010
MARKET CAP
34.61M
P/E (TTM)
-0.3598
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CELU last week (0316-0320)?
Weekly Report · 3d ago
Weekly Report: what happened at CELU last week (0309-0313)?
Weekly Report · 03/16 10:04
NexGel announces terms of agreement of license for products from Celularity
TipRanks · 03/12 12:55
NEXGEL Announces Consideration Terms Of Agreement To License And Acquire Portfolio Of Commercial-Stage Regenerative Biomaterial Products From Celularity; Consideration To Include $15M Upfront Cash Payment And Addl. $20M In Milestone Payments
Benzinga · 03/12 12:53
Nexgel to pay USD 15 million upfront to acquire Celularity regenerative biomaterials portfolio
Reuters · 03/12 12:45
NEXGEL INC - DEAL EXPECTED TO TRIPLE ANNUAL REVENUE TO $35 MLN AND MAKE COMPANY PROFITABLE UPON CLOSING
Reuters · 03/12 12:45
Celularity reiterates strategic commercialization partnership with NEXGEL
TipRanks · 03/12 12:35
NEXGEL Signs Agreement With Celularity To License And Acquire 6 Biomaterial Products; Stock Down
NASDAQ · 03/11 14:22
More
About CELU
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Biovance 3L, CentaFlex, Interfyl and Rebound products.

Webull offers Celularity Inc stock information, including NASDAQ: CELU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CELU stock methods without spending real money on the virtual paper trading platform.